Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Parra, M."'
Autor:
Lin L; From the GSK, Wavre, Belgium., Macias Parra M; National Institute of Pediatrics in Mexico City, Mexico DF, Mexico., Sierra VY; Centro de Atención e Investigación Médica (CAIMED), Yopal, Colombia., Salas Cespedes A; Investigaciones Científicas y Servicios de Alta Tecnología de Panamá (INDICASAT), Panama, Panama., Granados MA; Centro de Atención e Investigación Médica (CAIMED), Bogota, Colombia., Luque A; Centro de Atención e Investigación Médica (CAIMED), Bogota, Colombia., Karkada N; From the GSK, Wavre, Belgium., Castrejon Alba MM; GSK, Panama, Panama., Romano-Mazzotti L; GSK, Philadelphia, Pennsylvania., Borys D; From the GSK, Wavre, Belgium., Struyf F; From the GSK, Wavre, Belgium.
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2019 Oct; Vol. 38 (10), pp. 1061-1067.
Autor:
Van Dyke MK; From the *GSK Vaccines, Wavre, Belgium; †Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), Saint-Maur-des-Fossés, CHI Créteil and UPEC, France; ‡Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, and §Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa; ¶Unidad de Otorrinolaringologia, Hospital Dr Sotero del Rio, Puente Alto, Santiago, Chile; ‖Departamento de Infectologia, Instituto Nacional de Pediatría de la Secretaría de Salud (SSA), Mexico City, Mexico; **Otolaryngology Department, King Saud University & King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; ††ENT-Center, Prinzenweg 1, 82319 Starnberg, Germany; ‡‡Centros de Estudios Infectologia Pediatrica, Cali, Colombia; §§GSK Biologicals, Ciudad Panama, Panama; ¶¶Sección de ORL Pediátrica, Hospital Universitari Vall d'Hebron, Barcelona, Spain; and ‖‖Otolaryngology Department, Faculty of Medicine Chiang Mai University, Chiang Mai, Thailand., Pirçon JY, Cohen R, Madhi SA, Rosenblüt A, Macias Parra M, Al-Mazrou K, Grevers G, Lopez P, Naranjo L, Pumarola F, Sonsuwan N, Hausdorff WP
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2017 Mar; Vol. 36 (3), pp. 274-281.
Autor:
Martin JM; From the *Division of General Academic Pediatrics, Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania; †Pediatric Infectious Diseases Department, Instituto Nacional de Pediatria, Mexico City, Mexico; ‡Department of Pediatric Oncology, University Children's Hospital Brno, Brno, Czech Republic; §Antifungal Clinical Development, Pfizer Inc., New York, New York; ¶Global Established Pharma-Biostatistics, Pfizer Inc., New York, New York; ‖Department of Clinical Pharmacology, Pfizer Inc., Groton, Connecticut; **Global Established Pharma, Pfizer PFE, Paris, France; and ††Global Medical Affairs, Pfizer Inc., Groton, Connecticut., Macias-Parra M, Mudry P, Conte U, Yan JL, Liu P, Capparella MR, Aram JA
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2017 Jan; Vol. 36 (1), pp. e1-e13.
Autor:
Saltigeral Simental P; Instituto Nacional de Pediatria, Col. Coyoacan, Mexico., Macias Parra M, Mejía Valdéz J, Sosa Vázquez M, Castilla Serna L, González Saldaña N
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 1993 Sep; Vol. 12 (9), pp. 722-5.